Related Experiment Video
Updated: Feb 22, 2026
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Dynamic Rearrangement of Cell States Detected by Systematic Screening of Sequential Anticancer Treatments
Simon Koplev1, James Longden1, Jesper Ferkinghoff-Borg1
1Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
Abstract:
Signaling networks are nonlinear and complex, involving a large ensemble of dynamic interaction states that fluctuate in space and time. However, therapeutic strategies, such as combination chemotherapy, rarely consider the timing of drug perturbations. If we are to advance drug discovery for complex diseases, it will be essential to develop methods capable of identifying dynamic cellular responses to clinically relevant perturbations. Here, we present a Bayesian dose-response framework and the screening of an oncological drug matrix, comprising 10,000 drug combinations in melanoma and pancreatic cancer cell lines, from which we predict sequentially effective drug combinations. Approximately 23% of the tested combinations showed high-confidence sequential effects (either synergistic or antagonistic), demonstrating that cellular perturbations of many drug combinations have temporal aspects, which are currently both underutilized and poorly understood.
Insights
Most cancer drug combinations ignore timing, but this study found 23% have significant sequential effects. Understanding these temporal drug interactions is crucial for advancing cancer drug discovery and developing effective combination chemotherapy.
Area of Science:
- Computational biology
- Pharmacology
- Cancer research
Background:
- Cellular signaling networks are complex and dynamic, with interactions changing over time.
- Current cancer therapies, including combination chemotherapy, often overlook the temporal dynamics of drug perturbations.
Purpose of the Study:
- To develop a computational framework for identifying time-dependent drug effects.
- To investigate the sequential efficacy of drug combinations in cancer cell lines.
Main Methods:
- A Bayesian dose-response framework was developed.
- A large-scale screening of 10,000 oncological drug combinations was performed in melanoma and pancreatic cancer cell lines.
- The framework predicted sequentially effective drug combinations.
Main Results:
- Approximately 23% of tested drug combinations exhibited high-confidence sequential effects (synergistic or antagonistic).
- These findings highlight the significant temporal aspects of drug interactions in cancer cells.
- The study demonstrates the underutilization and poor understanding of these dynamic effects in current therapeutic strategies.
Conclusions:
- Drug combinations possess temporal characteristics that significantly impact cellular responses.
- Integrating dynamic analysis into drug discovery can reveal novel therapeutic strategies for complex diseases.
- This approach advances the understanding of combination chemotherapy and its potential for personalized treatment.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...